A single injection of the next-generation drug rademikibart markedly cut the rate and impact of acute exacerbations among ...

For weeks, falling asleep had been a nightly battle with tossing, turning, waiting for my mind to settle and my lungs to ...

No lecture. No shaming. No “I told you so.” Just another chance to do better with what I’d been given. And this time, I rose ...

Chronic obstructive pulmonary disease (COPD) is an inflammatory disorder that causes several symptoms which make breathing difficult. These include persistent cough with mucus, wheezing, and shortness ...

Yupelri (revefenacin) is not superior to Spiriva (tiotropium) at improving lung function in adults with severe chronic obstructive pulmonary disease (COPD), according to data from a Phase 4 clinical ...

Some teachers leave you with formulas and lab reports. Others leave you with something that follows you into the harder seasons of life, long after you’ve forgotten the periodic table. When I was ...

It’s not uncommon for those of us with chronic obstructive pulmonary disease (COPD) to suffer from cachexia, or wasting disease. A 2019 study found that people with cachexia or pre-cachexia had a ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google The experimental therapy tozorakimab from AstraZeneca was ...

DirectRx, a specialty pharmacy for people with chronic health disorders, is now part of the exclusive U.S. pharmacy network distributing Ohtuvayre (ensifentrine), a newly approved therapy for chronic ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google Note: This column describes the author’s experiences with ...

What types of exercise benefit patients with chronic obstructive pulmonary disease (COPD)? In my opinion, the quick answer is “all of them,” but let’s take a closer look. According to Harvard Health, ...

Breyna, a generic version of Symbicort (budesonide-formoterol), has been launched in the U.S. for eligible people with chronic obstructive pulmonary disease (COPD) and asthma. The inhaled medication — ...